| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.46 | 0.003 |